AAAAAA

   
Results: 1-9 |
Results: 9
The ups and downs of multiple sclerosis therapeutics
Authors: Hohlfeld, R Wiendl, H
Citation: R. Hohlfeld et H. Wiendl, The ups and downs of multiple sclerosis therapeutics, ANN NEUROL, 49(3), 2001, pp. 281-284
Biphasic cytotoxic mechanism of extracellular ATP on U-937 human histiocytic leukemia cells: involvement of adenosine generation
Authors: Schneider, C Wiendl, H Ogilvie, A
Citation: C. Schneider et al., Biphasic cytotoxic mechanism of extracellular ATP on U-937 human histiocytic leukemia cells: involvement of adenosine generation, BBA-MOL CEL, 1538(2-3), 2001, pp. 190-205
GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis
Authors: Wiendl, H Bien, CG Bernasconi, P Fleckenstein, B Elger, CE Dichgans, J Mantegazza, R Melms, A
Citation: H. Wiendl et al., GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis, NEUROLOGY, 57(8), 2001, pp. 1511-1514
Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G
Authors: Wiendl, H Behrens, L Maier, S Johnson, MA Weiss, EH Hohlfeld, R
Citation: H. Wiendl et al., Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G, ANN NEUROL, 48(4), 2000, pp. 679-684
Chronic encephalitis with epilepsy (Rasmussen syndrome, Rasmussen's encephalitis) - Infection, autoimmune disease or epiphenomenon?
Authors: Wiendl, H Stefan, H
Citation: H. Wiendl et H. Stefan, Chronic encephalitis with epilepsy (Rasmussen syndrome, Rasmussen's encephalitis) - Infection, autoimmune disease or epiphenomenon?, AKT NEUROL, 27(2), 2000, pp. 54-58
Multiple sclerosis: a current overview of failed and interrupted treatmenttrials
Authors: Wiendl, H Neuhaus, O Kappos, L Hohlfeld, R
Citation: H. Wiendl et al., Multiple sclerosis: a current overview of failed and interrupted treatmenttrials, NERVENARZT, 71(8), 2000, pp. 597-610
Multiple sclerosis: Comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells
Authors: Neuhaus, O Farina, C Yassouridis, A Wiendl, H Bergh, FT Dose, T Wekerle, H Hohlfeld, R
Citation: O. Neuhaus et al., Multiple sclerosis: Comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells, P NAS US, 97(13), 2000, pp. 7452-7457
Treatment of Rasmussen's encephalitis
Authors: Wiendl, H Neuhaus, O Stefan, H
Citation: H. Wiendl et al., Treatment of Rasmussen's encephalitis, DEUT MED WO, 124(31-32), 1999, pp. 937-939
Pathogenesis and diagnosis of Rasmussen's encephalitis
Authors: Wiendl, H Neuhaus, O Stefan, H
Citation: H. Wiendl et al., Pathogenesis and diagnosis of Rasmussen's encephalitis, DEUT MED WO, 124(30), 1999, pp. 901-904
Risultati: 1-9 |